Home » Stocks » NVIV

Invivo Therapeutics Holdings Corp. (NVIV)

Stock Price: $0.722 USD 0.008 (1.06%)
Updated Jun 16, 2021 10:11 AM EDT - Market open
Market Cap 25.83M
Revenue (ttm) n/a
Net Income (ttm) -8.88M
Shares Out 29.47M
EPS (ttm) -0.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 16
Last Price $0.722
Previous Close $0.715
Change ($) 0.008
Change (%) 1.06%
Day's Open 0.735
Day's Range 0.720 - 0.735
Day's Volume 91,747
52-Week Range 0.498 - 2.000

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord in...

3 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord in...

3 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the recent publication of a peer-reviewed manuscript in the Journal of Neurosurgery: Spine describing...

4 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the closing of its previously announced public offering of 18,750,000 shares of its common stock (or ...

7 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp.

9 months ago - Business Wire

About NVIV

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). The company is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusett... [Read more...]

Industry
Biotechnology
CEO
Richard Toselli
Employees
6
Stock Exchange
NASDAQ
Ticker Symbol
NVIV
Full Company Profile

Financial Performance

Financial Statements